191 related articles for article (PubMed ID: 11973331)
1. Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.
Tanno B; Negroni A; Vitali R; Pirozzoli MC; Cesi V; Mancini C; Calabretta B; Raschellà G
J Biol Chem; 2002 Jun; 277(26):23172-80. PubMed ID: 11973331
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein 5: contribution to growth and differentiation of neuroblastoma cells.
Cesi V; Vitali R; Tanno B; Giuffrida ML; Sesti F; Mancini C; Raschellà G
Ann N Y Acad Sci; 2004 Dec; 1028():59-68. PubMed ID: 15650232
[TBL] [Abstract][Full Text] [Related]
3. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers of endometrial epithelial cell mitogenesis mediated by the Sp/Krüppel-like factor BTEB1.
Simmen RC; Zhang XL; Michel FJ; Min SH; Zhao G; Simmen FA
DNA Cell Biol; 2002 Feb; 21(2):115-28. PubMed ID: 11953011
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
6. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway.
Duan C; Liimatta MB; Bottum OL
J Biol Chem; 1999 Dec; 274(52):37147-53. PubMed ID: 10601276
[TBL] [Abstract][Full Text] [Related]
8. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
[TBL] [Abstract][Full Text] [Related]
9. Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells.
Ratajczak MZ; Perrotti D; Melotti P; Powzaniuk M; Calabretta B; Onodera K; Kregenow DA; Machalinski B; Gewirtz AM
Blood; 1998 Mar; 91(6):1934-46. PubMed ID: 9490676
[TBL] [Abstract][Full Text] [Related]
10. C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.
Verbeek W; Gombart AF; Chumakov AM; Müller C; Friedman AD; Koeffler HP
Blood; 1999 May; 93(10):3327-37. PubMed ID: 10233885
[TBL] [Abstract][Full Text] [Related]
11. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta.
Guo S; Cichy SB; He X; Yang Q; Ragland M; Ghosh AK; Johnson PF; Unterman TG
J Biol Chem; 2001 Mar; 276(11):8516-23. PubMed ID: 11116148
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
14. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
Kiess W; Koepf G; Christiansen H; Blum WF
Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression.
Duan C; Clemmons DR
J Biol Chem; 1995 Oct; 270(42):24844-51. PubMed ID: 7559606
[TBL] [Abstract][Full Text] [Related]
16. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
Foos G; Natour S; Klempnauer KH
Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
18. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription.
Tomizawa M; Kumar A; Perrot V; Nakae J; Accili D; Rechler MM
J Biol Chem; 2000 Mar; 275(10):7289-95. PubMed ID: 10702299
[TBL] [Abstract][Full Text] [Related]
19. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
Miglarese MR; Halaban R; Gibson NW
Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]